Related Experiment Video

Updated: Jun 24, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis

U Egermann1, Z Stanga, A Ramin

  • 1Department of Internal Medicine, Inselspital, Bern, Switzerland.

Antimicrobial Agents and Chemotherapy
|April 15, 2009
PubMed

Insights

The combination of daptomycin and ceftriaxone demonstrated the highest efficacy against pneumococcal meningitis in rabbits. Dexamethasone slightly reduced daptomycin

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Neuroscience

Background:

  • Bacterial meningitis remains a critical global health challenge.
  • Optimizing antibiotic penetration and efficacy in the central nervous system is crucial.
  • Daptomycin and ceftriaxone are key antibiotics with varying meningeal penetration profiles.

Purpose of the Study:

  • To evaluate the cerebrospinal fluid penetration and bactericidal efficacy of daptomycin.
  • To assess the impact of dexamethasone on daptomycin's activity in pneumococcal meningitis.
  • To determine the combined efficacy of daptomycin and ceftriaxone in a rabbit meningitis model.

Main Methods:

  • Experimental rabbit model of Streptococcus pneumoniae meningitis.
  • Administration of daptomycin, dexamethasone, and ceftriaxone.
  • Measurement of daptomycin cerebrospinal fluid penetration.
  • Assessment of bactericidal activity and treatment efficacy.

Main Results:

  • Daptomycin penetration into inflamed meninges was significantly reduced by dexamethasone (6% to 2%).
  • The combination of daptomycin and ceftriaxone showed the highest bactericidal efficacy.
  • Dexamethasone had only a marginal effect on daptomycin's antibacterial activity.

Conclusions:

  • Daptomycin plus ceftriaxone is a highly efficacious regimen for pneumococcal meningitis.
  • Dexamethasone co-administration may reduce daptomycin's CNS penetration but not significantly impair its activity.
  • This combination warrants further investigation for empirical bacterial meningitis therapy.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...